David B. Agus, M.D. is a professor of medicine and engineering at the University of Southern California Keck School of Medicine and Viterbi School of Engineering and heads USC’s Westside Cancer Center and the Center for Applied Molecular Medicine. He is one of the world’s leading cancer doctors, and the co-founder of two pioneering personalized medicine companies, Navigenics and Applied Proteomics. Agus is an international leader in new technologies and approaches for personalized healthcare, chairs the Global Agenda Council (GAC) on Genetics for the World Economic Forum, and speaks regularly at TEDMED, the Aspen Ideas Festival and the World Economic Forum. He has received numerous awards, including the 2009 GQ Magazine Rockstar of Science Award. Agus’ first book, The End of Illness, was published in January, 2012 from Simon & Schuster and is a New York Times #1 best seller.
Michael Quick is the executive vice provost at the University of Southern California and professor of biological sciences in the USC Dana and David Dornsife College of Letters, Arts and Sciences. Quick is responsible for advancing excellence and innovation in the undergraduate curriculum and is working to bring greater distinction to USC’s Ph.D., professional and post-doctoral programs. Quick received his Ph.D. in Neuroscience from Emory University and studied as a post-doctoral research fellow at the California Institute of Technology. His scholarship focuses on how drugs of abuse such as cocaine and nicotine, and therapeutic drugs such as antidepressants and anti-epileptic medications, alter the signaling properties of nerve cells.